Potential therapeutic benefit of spinal cord stimulation in restless legs syndrome: scoping review and mechanistic considerations.
Autor: | Pagani-Estévez GL; Department of Interventional and Surgical Pain Management, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH 45220, United States., Holland MT; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, United States., Tippmann-Peikert M; Department of Neurology, Mayo Clinic, Rochester, MN 55905, United States.; Center for Sleep Medicine, Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, United States., Benarroch EE; Department of Neurology, Mayo Clinic, Rochester, MN 55905, United States., Silber MH; Department of Neurology, Mayo Clinic, Rochester, MN 55905, United States.; Center for Sleep Medicine, Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, United States., Carvalho DZ; Department of Neurology, Mayo Clinic, Rochester, MN 55905, United States.; Center for Sleep Medicine, Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Pain medicine (Malden, Mass.) [Pain Med] 2023 Oct 13; Vol. 24 (Supplement_2), pp. S18-S23. |
DOI: | 10.1093/pm/pnad089 |
Abstrakt: | Background: Restless legs syndrome (RLS) is a prevalent sensorimotor disorder that can dramatically impair sleep quality, daytime function, and quality of life. Although many patients benefit from standard pharmacological therapy, some patients suffer from insufficient treatment response or medication intolerance. Novel treatment approaches are therefore necessary. Objective: Given the overlap between RLS and pain syndromes in both pathophysiological mechanisms and certain treatment options, we aimed to perform a scoping review of the available evidence on spinal cord stimulation (SCS) for RLS and discuss potential mechanistic implications. Methods: We identified a total of 16 cases of patients with RLS who underwent SCS, all from case reports or case series. Discussion: The published evidence is insufficient to assess SCS efficacy in patients with RLS, but SCS remains a promising investigational therapy in RLS on the basis of its potential mitigatory effects in the central hyperexcitability of the sensorimotor cortex through neuromodulation of spinal, subcortical, and cortical areas. A call for further research in this field is presented, with suggestions for future directions and trial designs. (© The Author(s) 2023. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.) |
Databáze: | MEDLINE |
Externí odkaz: |